Ev. Planken et al., SELECTIVE RESPONSE OF CD5(-CELL MALIGNANCIES TO ACTIVATION OF THE CD72 ANTIGEN() B), Clinical immunology and immunopathology, 87(1), 1998, pp. 42-49
The function of the simultaneous expression of CD5 and its ligand CD72
on B cell malignancies like chronic lymphocytic leukemia and mantle c
ell lymphoma was assessed. It is unknown if reciprocal interactions be
tween CD72 and CD5 exert an autocrine growth-promoting or -inhibiting
effect. CD5(+) (n = 13) and CD5(-) (n = 9) B cell malignancies were cu
ltured with the anti(-) CD72 mAb WL225. For comparison, five other ant
i-CD72 mAbs were tested, Only CD5(+) B cell malignancies proliferated
upon CD72 activation (9 out of 13 cases). A strong suppressive effect
of IL-4 on the anti-CD72-induced [H-3]thymidine incorporation, partial
ly caused by downmodulation of the CD72 expression, was seen, Stimulat
ion of the CD5 antigen by L cells transfected with human CD72 (LhCD72)
and the anti-CD5 mAb 1C12 exerted no (n = 9) or a minor effect (2 out
of 8 cases), respectively. Finally, the results of CD72 stimulation w
ere compared with CD40 stimulation, as this ''CD40 system'' is an effe
ctive method for stimulating B cell malignancies. In 4 of the 7 anti-C
D72 responsive cases a costimulatory effect was seen. (C) 1998 Academi
c Press.